Phase I study of a chloroquine-gemcitabine combination in patients with metastatic or unresectable pancreatic cancer.

The addition of chloroquine to gemcitabine was well tolerated and showed promising effects on the clinical response to the anti-cancer chemotherapy. Based on these initial results, the efficacy of the gemcitabine-chloroquine combination should be further assessed.